Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas-Reference-Cited by-同舟云学术

Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas

Published:2006-11-01 Issue:21 Volume:98 Page:1546-1557
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Lun XueQing,Senger Donna L.,Alain Tommy,Oprea Andra,Parato Kelley,Stojdl Dave,Lichty Brian,Power Anthony,Johnston Randal N.,Hamilton Mark,Parney Ian,Bell John C.,Forsyth Peter A.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/98/21/1546/7687972/djj413.pdf

Reference67 articles.

1. Scott JN, Rewcastle NB, Brasher PM, Fulton D, Mackinnon JA, Hamilton M, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol1999 ; 46 : 183 –8.

2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med2005 ; 352 : 987 –96.

3. Fisher PG, Buffler PA. Malignant gliomas in 2005 : where to GO from here? JAMA2005 ; 293 : 615 –7.

4. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol (Berl)2005 ; 109 : 93 –108.

5. Castro MG, Cowen R, Williamson IK, David A, Jimenez-Dalmaroni MJ, Yuan X, et al. Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther2003 ; 98 : 71 –108.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus;Cancers;2023-09-27

2. Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme;MedComm – Oncology;2023-01-31

3. SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation;Proceedings of the National Academy of Sciences;2022-07-25

4. CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma;Cancer Research;2022-07-06

5. SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation;2022-01-20